Silo Pharma, Inc. (SILO)
1.26
-0.03
(-2.33%)
USD |
NASDAQ |
Nov 06, 10:07
Silo Pharma Price to Book Value : 0.2911 for Nov. 6, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 05, 2026 | 0.298 |
| November 04, 2026 | 0.3072 |
| November 03, 2026 | 0.2956 |
| November 02, 2026 | 0.2795 |
| October 30, 2026 | 0.2841 |
| October 29, 2026 | 0.2887 |
| October 28, 2026 | 0.3095 |
| October 27, 2026 | 0.298 |
| October 26, 2026 | 0.2679 |
| October 23, 2026 | 0.2725 |
| October 22, 2026 | 0.2725 |
| October 21, 2026 | 0.2772 |
| October 20, 2026 | 0.2772 |
| October 19, 2026 | 0.261 |
| October 16, 2026 | 0.2725 |
| October 15, 2026 | 0.2772 |
| October 14, 2026 | 0.2772 |
| October 13, 2026 | 0.2818 |
| October 12, 2026 | 0.3441 |
| October 09, 2026 | 0.3395 |
| October 08, 2026 | 0.3349 |
| October 07, 2026 | 0.3326 |
| October 06, 2026 | 0.3349 |
| October 05, 2026 | 0.3441 |
| October 02, 2026 | 0.3368 |
| Date | Value |
|---|---|
| October 01, 2026 | 0.3465 |
| September 30, 2026 | 0.3488 |
| September 29, 2026 | 0.3719 |
| September 28, 2026 | 0.3811 |
| September 25, 2026 | 0.4042 |
| September 24, 2026 | 0.4042 |
| September 23, 2026 | 0.4088 |
| September 22, 2026 | 0.3973 |
| September 21, 2026 | 0.403 |
| September 18, 2026 | 0.425 |
| September 17, 2026 | 0.3973 |
| September 16, 2026 | 0.4065 |
| September 15, 2026 | 0.4481 |
| September 14, 2026 | 0.4781 |
| September 11, 2026 | 0.485 |
| September 10, 2026 | 0.486 |
| September 09, 2026 | 0.4966 |
| September 08, 2026 | 0.5266 |
| September 04, 2026 | 0.5543 |
| September 03, 2026 | 0.5659 |
| September 02, 2026 | 0.5774 |
| September 01, 2026 | 0.5636 |
| August 31, 2026 | 0.5728 |
| August 28, 2026 | 0.5867 |
| August 27, 2026 | 0.5867 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.756 |
| Alnylam Pharmaceuticals, Inc. | 5.852 |
| Anika Therapeutics, Inc. | 1.638 |
| Savara, Inc. | 6.534 |
| Vericel Corp. | 7.116 |
Price to Book Value Related Metrics
| PS Ratio | 20.51 |
| Price | 1.26 |
| Earnings Yield | -423.7% |
| Market Cap | 1.422M |